You can email us at, or call us on 01202 539791.Email: Phone: 01202 539791.



Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST). Sunitinib was the first cancer drug simultaneously approved for two different indications.

Product Details

Category Cancer Research and Antivirals
Price POA
CAS Number 557795-19-4
Formula C22H27FN4O2 · C4H6O5
Molecular Weight 532.56
Purity 99.0%
Appearance yellow powder
Availability In Stock
Storage Conditions +4°C

Product Enquiry

Send us your enquiry for Sunitinib. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.

We value your input so if you have suggestions regarding new applications for Sunitinib email us and we will include your contribution on the website.

Enquire about product

Back to Top